Literature DB >> 10926946

Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke.

P Jousilahti1, D Rastenyte, J Tuomilehto.   

Abstract

BACKGROUND AND
PURPOSE: There is still conflicting evidence regarding a link between alcohol drinking and the risk of stroke. In most prospective studies, the assessment of the alcohol drinking has been based on self-reporting, which may be unreliable. The aim of the present study was to examine the relationship between stroke and both the self-reported alcohol drinking and the serum gamma-glutamyl transferase (GGT) concentration, which was regarded as a biological marker of alcohol drinking.
METHODS: A prospective cohort study of 14 874 Finnish men and women aged 25 to 64 years who participated in a cardiovascular risk-factor survey in 1982 or 1987. The following risk factors, determined at baseline, were included in data analyses: self-reported alcohol drinking, GGT, smoking, blood pressure, serum cholesterol, and body mass index. The cohorts were followed until the end of 1994. Stroke events were identified through the national death registry and hospital discharge registry by computerized record linkage.
RESULTS: Serum GGT concentration was associated with the risk of total and ischemic stroke in both genders. There was also a significant association among men between GGT and the risk of intracerebral hemorrhage and among women between GGT and the risk of subarachnoid hemorrhage. The relationships remained statistically significant also after adjustment for other risk factors. Self-reported alcohol drinking did not associate with any type of stroke.
CONCLUSIONS: These results support the hypothesis that excessive alcohol drinking is related to an increased risk of stroke. Biological markers of alcohol drinking, such as serum GGT level, are useful for the assessment of risks related to alcohol drinking.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926946     DOI: 10.1161/01.str.31.8.1851

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  36 in total

Review 1.  Gamma-glutamyl transferase and cardiovascular disease.

Authors:  Gjin Ndrepepa; Adnan Kastrati
Journal:  Ann Transl Med       Date:  2016-12

2.  Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress.

Authors:  Simona Bo; Roberto Gambino; Marilena Durazzo; Sabrina Guidi; Elisa Tiozzo; Federica Ghione; Luigi Gentile; Maurizio Cassader; Gian Franco Pagano
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

3.  Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study.

Authors:  Saverio Stranges; Maurizio Trevisan; Joan M Dorn; Jacek Dmochowski; Richard P Donahue
Journal:  Hypertension       Date:  2005-10-03       Impact factor: 10.190

4.  Gamma-glutamyltransferase and diabetes--a 4 year follow-up study.

Authors:  D-H Lee; M-H Ha; J-H Kim; D C Christiani; M D Gross; M Steffes; R Blomhoff; D R Jacobs
Journal:  Diabetologia       Date:  2003-03-01       Impact factor: 10.122

5.  The relationship of management modality in Saudi patients with type 2 diabetes to components of metabolic syndrome, γ glutamyl transferase and highly sensitive C-reactive protein.

Authors:  Suhad M Bahijri; Maimoona Ahmed; Khalid Al-Shali; Samia Bokhari; Amani Alhozali; Anwar Borai; Amani Gusti; Ghada Ajabnoor; Ahmed Alghamdi; Mohammed Asiri; Jaakko Tuomilehto
Journal:  Ther Adv Chronic Dis       Date:  2016-07-15       Impact factor: 5.091

6.  The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome.

Authors:  Arie Steinvil; Itzhak Shapira; Orit Kliuk Ben-Bassat; Michael Cohen; Yaffa Vered; Shlomo Berliner; Ori Rogowski
Journal:  Cardiovasc Diabetol       Date:  2010-07-15       Impact factor: 9.951

7.  Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events.

Authors:  Hamdy Abd El Azeem; El-Shazly Abdul Khalek; Hazem El-Akabawy; Hussein Naeim; Hammouda Abdul Khalik; Abdul Aziz Alfifi
Journal:  J Saudi Heart Assoc       Date:  2013-10

8.  Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes?

Authors:  D-H Lee; M W Steffes; D R Jacobs
Journal:  Diabetologia       Date:  2007-12-11       Impact factor: 10.122

9.  Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults.

Authors:  Alexander M Strasak; Cecily C Kelleher; Jochen Klenk; Larry J Brant; Elfriede Ruttmann; Kilian Rapp; Hans Concin; Günter Diem; Karl P Pfeiffer; Hanno Ulmer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-10       Impact factor: 8.311

10.  Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study.

Authors:  Alexander M Strasak; Kilian Rapp; Larry J Brant; Wolfgang Hilbe; Martin Gregory; Willi Oberaigner; Elfriede Ruttmann; Hans Concin; Günter Diem; Karl P Pfeiffer; Hanno Ulmer
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.